These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 24302387

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Detecting qualitative interactions in clinical trials with binary responses.
    Kitsche A.
    Pharm Stat; 2014; 13(5):309-15. PubMed ID: 25049176
    [Abstract] [Full Text] [Related]

  • 3. How to deal with multiple treatment or dose groups in randomized clinical trials?
    Hothorn LA.
    Fundam Clin Pharmacol; 2007 Apr; 21(2):137-54. PubMed ID: 17391286
    [Abstract] [Full Text] [Related]

  • 4. Methods for exploring treatment effect heterogeneity in subgroup analysis: an application to global clinical trials.
    Schou IM, C Marschner I.
    Pharm Stat; 2015 Apr; 14(1):44-55. PubMed ID: 25376518
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Asymptotic simultaneous confidence intervals for many-to-one comparisons of binary proportions in randomized clinical trials.
    Schaarschmidt F, Biesheuvel E, Hothorn LA.
    J Biopharm Stat; 2009 Apr; 19(2):292-310. PubMed ID: 19212881
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multiple comparisons and multiple contrasts in randomized dose-response trials--confidence interval oriented approaches.
    Hothorn LA.
    J Biopharm Stat; 2006 Apr; 16(5):711-31. PubMed ID: 17037267
    [Abstract] [Full Text] [Related]

  • 9. [Low p-values are not all!].
    Lindberg G.
    Lakartidningen; 2002 Oct 03; 99(40):3979; author reply 3979. PubMed ID: 12422764
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Population enrichment designs: case study of a large multinational trial.
    Mehta CR, Gao P.
    J Biopharm Stat; 2011 Jul 03; 21(4):831-45. PubMed ID: 21516572
    [Abstract] [Full Text] [Related]

  • 14. The presentation of statistics.
    Bryant TN.
    Pediatr Allergy Immunol; 1998 Aug 03; 9(3):108-15. PubMed ID: 9814723
    [Abstract] [Full Text] [Related]

  • 15. Statistical significance versus clinical relevance. Part II. The use and interpretation of confidence intervals.
    Luus HG, Müller FO, Meyer BH.
    S Afr Med J; 1989 Dec 02; 76(11):626-9. PubMed ID: 2595492
    [Abstract] [Full Text] [Related]

  • 16. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG, Siu CO.
    Am J Psychiatry; 2009 Nov 02; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract] [Full Text] [Related]

  • 17. Confidence intervals versus p-values for interpretation of clinical trial results: introduction.
    Pledger GW.
    J Biopharm Stat; 1993 Sep 02; 3(2):237-42. PubMed ID: 8220405
    [Abstract] [Full Text] [Related]

  • 18. A ratio-to-control Williams-type test for trend.
    Hothorn LA, Djira GD.
    Pharm Stat; 2011 Sep 02; 10(4):289-92. PubMed ID: 20936714
    [Abstract] [Full Text] [Related]

  • 19. Randomized clinical trial: myths around elementary statistical principles.
    Edler L, Kopp-Schneider A.
    Onkologie; 2003 Dec 02; 26(6):551-6. PubMed ID: 14709929
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.